BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

weaken

Expert replies
by gmatnmein2010 » Sat Feb 13, 2010 1:35 am
Damaged nerves in the spinal cord do not regenerate themselves naturally, nor even under the spur of nerve-growth stimulants. The reason, recently discovered, is the presence of nerve-growth inhibitors in the spinal cord. Antibodies that deactivate those inhibitors have now been developed. Clearly, then, nerve repair will be a standard medical procedure in the foreseeable future.
Which of the following, if true, casts the most serious doubt on the accuracy of the prediction above?

(A) Prevention of the regeneration of damaged nerves is merely a by-product of the main function in the human body of the substances inhibiting nerve growth.
(B) Certain nerve-growth stimulants have similar chemical structures to those of the antibodies against nerve-growth inhibitors.
(C) Nerves in the brain are similar to nerves in the spinal cord in their inability to regenerate themselves naturally.
(D) Researchers have been able to stimulate the growth of nerves not located in the spinal cord by using only nerve-growth stimulants.
(E) Deactivating the substances inhibiting nerve growth for an extended period would require a steady supply of antibodies.
Join the discussion
Source: — Critical Reasoning |

by mgmt_gmat » Sat Feb 13, 2010 2:35 am
IMO (E)
Join the discussion

by thephoenix » Sat Feb 13, 2010 3:01 am
A) Prevention of the regeneration of damaged nerves is merely a by-product of the main function in the human body of the substances inhibiting nerve growth.
This implies that there are many fiunctions of this substance apart from inhibitiion....So every time there is a procedure doctors should take care that other functions should not get affected and hence doctors cannot do the same thing for every patient evrytime. It will depend from patient to patient.

(B) Certain nerve-growth stimulants have similar chemical structures to those of the antibodies against nerve-growth inhibitors.
irrelevant

(C) Nerves in the brain are similar to nerves in the spinal cord in their inability to regenerate themselves naturally.
irrelevant

(D) Researchers have been able to stimulate the growth of nerves not located in the spinal cord by using only nerve-growth stimulants. no effect on conc......

(E) Deactivating the substances inhibiting nerve growth for an extended period would require a steady supply of antibodies.
may or may not inhibit the procedure become standard

IMO A
Join the discussion

by komal » Sun Feb 14, 2010 5:33 am
gmatnmein2010 wrote:Damaged nerves in the spinal cord do not regenerate themselves naturally, nor even under the spur of nerve-growth stimulants. The reason, recently discovered, is the presence of nerve-growth inhibitors in the spinal cord. Antibodies that deactivate those inhibitors have now been developed. Clearly, then, nerve repair will be a standard medical procedure in the foreseeable future.
Which of the following, if true, casts the most serious doubt on the accuracy of the prediction above?

(A) Prevention of the regeneration of damaged nerves is merely a by-product of the main function in the human body of the substances inhibiting nerve growth.
(B) Certain nerve-growth stimulants have similar chemical structures to those of the antibodies against nerve-growth inhibitors.
(C) Nerves in the brain are similar to nerves in the spinal cord in their inability to regenerate themselves naturally.
(D) Researchers have been able to stimulate the growth of nerves not located in the spinal cord by using only nerve-growth stimulants.
(E) Deactivating the substances inhibiting nerve growth for an extended period would require a steady supply of antibodies.
(A) is correct as it is clearly mentioned that 'prevention of the regeneration of damaged nerves is merely a by-product of the inhibitors'.. which leads us to presume that these inhibitors perform some other main functions.. thus using antibodies which render these inhibitors inactive would affect some other functions primarily performed by the inhibitors. So it can't be followed as a standard medical procedure.
Join the discussion